UA55225U - method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
- Google Patents
method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201006155UpriorityCriticalpatent/UA55225U/en
Publication of UA55225UpublicationCriticalpatent/UA55225U/en
A method for assessment of treatment efficiency for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type with benazepril. Prior to treatment withbenazepril to a patient in the state of rest the Doppler-echocardiography is carried out and transmitral blood circulation is determined by measurement of rate of early diastolic filling. After treatment with benasepril the similar examination is carried out. If the rate of early diastolic filling of left ventricle is increased on 15 % and more comparative to the rate prior to treatment, than the hemodynamic result and antianginal effect are estimated as positives.
UAU201006155U2010-05-212010-05-21method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
UA55225U
(en)
method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assessing efficacy of atorvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
method for evaluating of treatment effectiveness of patients with ischemic heart disease and angina pectoris, and hypertension with diastolic impairment of the left ventricle by 'hypertrophy' type
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
Method for assessing efficacy of efonidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for estimation of efficiency of treatment with NITRENDIPINE of patients with ischemic heart disease with stenocardia and arterial hypertensia with disorder of left ventricle diastolic function by “hypertrophic” type
Method for assessing efficacy of aranidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type